Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device
Thursday, May 19, 2022Zealand Pharma AS a biotechnology company focused on the discovery and development of innovative peptidebased medicines today announced it has entered into an asset purchase agreement with MannKind Corporation Nasdaq MNKD to sell the VGo insulin deli...
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19
Wednesday, May 18, 2022AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd RQ Bio for a portfolio of earlystage monoclonal antibodies mAbs targeted against SARSCoV the virus that causes COVID Under the agreement AstraZeneca has acquired an exclusive...
Proscia Introduces AI-Powered Quality Control to Accelerate Data-Driven Drug Development
Wednesday, May 18, 2022Proscia a leader in digital and computational pathology solutions has introduced an automated quality control application that leverages artificial intelligence to improve quality and efficiency in datadriven drug development In launching automated q...
PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing
Tuesday, May 17, 2022PerkinElmer Inc a global leader committed to innovating for a healthier world today announced the availability of ultrarapid whole genome sequencing urWGS through PerkinElmer Genomics This addition to the Companys portfolio of whole genome sequencing...
Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca
Tuesday, May 17, 2022Proteros biostructures GmbH an expert in integrated structurebased drug discovery announces today an expansion of its collaboration with AstraZeneca focused on the discovery and development of novel epigenetic drugs The new multiyear agreement builds...
Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases
Monday, May 16, 2022Inmagene Biopharmaceuticals announces that today the US Food and Drug Administration FDA cleared its investigational new drug IND application for the drug candidate IMG a noncovalent reversible thirdgeneration Bruton Tyrosine Kinase BTK inhibitor to...
Neurocrine Biosciences Receives Orphan Drug Designation for Valbenazine as a Treatment for Chorea Associated with Huntington Disease
Friday, May 13, 2022Neurocrine Biosciences Inc announced that it has received Orphan Drug Designation from the US Food and Drug Administration FDA for valbenazine as a treatment for Huntington disease HD The treatment of chorea associated with HD is within the scope of...
Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014
Friday, May 13, 2022Mindset Pharma Inc a drug discovery and development company focused on creating optimized and patentable nextgeneration psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs today announced that it is making h...
Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases
Thursday, May 12, 2022Nuvig Therapeutics Inc announced today the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function To support this mission the company...
Neuvivo Begins Manufacturing of NP001 for Treatment of ALS
Thursday, May 12, 2022Neuvivo a biopharmaceutical company dedicated to delivering an effective safe ALS treatment to patients today announced that it has initiated cGMP manufacturing of NP for the treatment of ALS Lou Gehrigs Disease The company expects to have product a...
